US OptionsDetailed Quotes
FLR241115P22500
- 0.00
- 0.000.00%
15min DelayClose Nov 7 09:30 ET
0.00High0.00Low
0.00Open0.00Pre Close0 Volume0 Open Interest22.50Strike Price0.00Turnover0.00%IV61.82%PremiumNov 15, 2024Expiry Date0.00Intrinsic Value100Multiplier8DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma43.65Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Fluor Stock Discussion
Sign in to post a comment
Like it, or not? Nuclear Energy, and Uranium, are vital. <~ period.
Microsoft’s play to reopen (and rename) Three Mile Island, Gates’ backing of TERRA, Amazon’s deal with TALEN, Google’s with KAIROS,… goin’ nuclear, folks: the cost of entry has gone up, buUut… look for pullbacks, and maybe long-term.
The modern Small Modular Reactor (SMR) requires High Assay Low-Enrichment Uranium (HALEU), soOo… keep those Acronyms In Mind (AIM) if you’re in...
Microsoft’s play to reopen (and rename) Three Mile Island, Gates’ backing of TERRA, Amazon’s deal with TALEN, Google’s with KAIROS,… goin’ nuclear, folks: the cost of entry has gone up, buUut… look for pullbacks, and maybe long-term.
The modern Small Modular Reactor (SMR) requires High Assay Low-Enrichment Uranium (HALEU), soOo… keep those Acronyms In Mind (AIM) if you’re in...
2
3
On Saturday, Donald Trump was shot at a campaign rally in Pennsylvania, which could be a key moment that completely disrupts the US election landscape this year. Following the incident, data from Polymarket shows that Trump's chances of winning the election have skyrocketed to 71%.
After shooting, Bitcoin price briefly surpassed $63,000. $Trump Media & Technology (DJT.US)$ surged over 70% in Mond...
After shooting, Bitcoin price briefly surpassed $63,000. $Trump Media & Technology (DJT.US)$ surged over 70% in Mond...
134
27
Insiders selling shares, particularly below current price, may be a negative signal. Despite this, the level of insider ownership indicates alignment with common shareholders. The absence of insider trading in the last quarter and recent transactions make us wary about Fluor.
1
Despite Fluor's lower than average ROE, the company demonstrates strong earnings growth and financial performance, likely due to high earnings retention and efficient management. Industry forecasts indicate that this earnings growth is expected to continue.
1
Pre-Market Stock Movers
Gapping up
$Intel (INTC.US)$ popped 2.5% after the chipmaker announced it would be operating its programmable chip unit as a standalone business complete. Intel plans to conduct an initial public offering for the unit within the next two to three years.
$Fluor (FLR.US)$ Shares climbed 2.4% following an upgrade to buy at UBS. The firm is bullish on the stock thanks to progress on legacy projects a...
Gapping up
$Intel (INTC.US)$ popped 2.5% after the chipmaker announced it would be operating its programmable chip unit as a standalone business complete. Intel plans to conduct an initial public offering for the unit within the next two to three years.
$Fluor (FLR.US)$ Shares climbed 2.4% following an upgrade to buy at UBS. The firm is bullish on the stock thanks to progress on legacy projects a...
22
1
Gapping up
In reaction to earnings/guidance:
• $Comtech Telecommunications (CMTL.US)$ +2.1%, $Micron Technology (MU.US)$+1.5%
Other news:
• $Amylyx Pharmaceuticals (AMLX.US)$ +9.3% (receives FDA approval for Relyvrio)
• $Ready Capital (RC.US)$ +4.9% (increases share buyback authorization by $25 mln)
• $Blue Apron (APRN.US)$ +2.5% (CFO to resign)
• $Fluor (FLR.US)$ +2.3% (US Dept of Energy extends Fluor-led Savannah River contract)
• $Immuneering (IMRX.US)$ +1.6% (re...
In reaction to earnings/guidance:
• $Comtech Telecommunications (CMTL.US)$ +2.1%, $Micron Technology (MU.US)$+1.5%
Other news:
• $Amylyx Pharmaceuticals (AMLX.US)$ +9.3% (receives FDA approval for Relyvrio)
• $Ready Capital (RC.US)$ +4.9% (increases share buyback authorization by $25 mln)
• $Blue Apron (APRN.US)$ +2.5% (CFO to resign)
• $Fluor (FLR.US)$ +2.3% (US Dept of Energy extends Fluor-led Savannah River contract)
• $Immuneering (IMRX.US)$ +1.6% (re...
10
Gainers:
• $Canoo (GOEV.US)$ +71.3% (receives purchase order of 4500 Canoo Electric Delivery Vehicles from Walmart)
• $Aldeyra Therapeutics (ALDX.US)$ +14.1% (achieved primary endpoints in dry eye disease chamber crossover clinical trial)
• $Westport Fuel (WPRT.US)$ +10.9% (awarded 38 mln program)
• $Greenwich LifeSciences (GLSI.US)$ +5.9% (FDA has removed the clinical hold permitting the Flamingo-01 Phase III clinical trial to proceed...
• $Canoo (GOEV.US)$ +71.3% (receives purchase order of 4500 Canoo Electric Delivery Vehicles from Walmart)
• $Aldeyra Therapeutics (ALDX.US)$ +14.1% (achieved primary endpoints in dry eye disease chamber crossover clinical trial)
• $Westport Fuel (WPRT.US)$ +10.9% (awarded 38 mln program)
• $Greenwich LifeSciences (GLSI.US)$ +5.9% (FDA has removed the clinical hold permitting the Flamingo-01 Phase III clinical trial to proceed...
14
Gainers:
• $La-Z-Boy (LZB.US)$ +9.3% (In reaction to earnings/guidance)
• $Enanta Pharmaceuticals (ENTA.US)$ +6.7% (ENTA files patent infringement lawsuit against $Pfizer (PFE.US)$)
• $Ikena Oncology (IKNA.US)$ +6.6% (granted Fast Track designation for IK-930)
• $BridgeBio Pharma (BBIO.US)$ +6.4% (Announces Early Positive Data for BBP-812)
• $Krystal Biotech (KRYS.US)$ +5% (submits Biologies License Application to FDA seeking approval of B-V...
• $La-Z-Boy (LZB.US)$ +9.3% (In reaction to earnings/guidance)
• $Enanta Pharmaceuticals (ENTA.US)$ +6.7% (ENTA files patent infringement lawsuit against $Pfizer (PFE.US)$)
• $Ikena Oncology (IKNA.US)$ +6.6% (granted Fast Track designation for IK-930)
• $BridgeBio Pharma (BBIO.US)$ +6.4% (Announces Early Positive Data for BBP-812)
• $Krystal Biotech (KRYS.US)$ +5% (submits Biologies License Application to FDA seeking approval of B-V...
8
1
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
Gainers:
• $Signet Jewelers (SIG.US)$ +7.6% (In reaction to earnings/guidance)
• $Oxford Industries (OXM.US)$ +6.3% (In reaction to earnings/guidance)
• $BridgeBio Pharma (BBIO.US)$ +5%(to Present Phase 2b Data and Pivotal Phase 3 Study Design of Encaleret in Autosomal Dominant Hypocalcemia Type 1 (ADH1) at the Endocrine Society (ENDO) 2022 Annual Conference)
• $Greif (GEF.US)$ +4.6% (In reaction to earnings/guidance)
• $Olema Pharmaceuticals (OLMA.US)$ +4.3% (an...
• $Signet Jewelers (SIG.US)$ +7.6% (In reaction to earnings/guidance)
• $Oxford Industries (OXM.US)$ +6.3% (In reaction to earnings/guidance)
• $BridgeBio Pharma (BBIO.US)$ +5%(to Present Phase 2b Data and Pivotal Phase 3 Study Design of Encaleret in Autosomal Dominant Hypocalcemia Type 1 (ADH1) at the Endocrine Society (ENDO) 2022 Annual Conference)
• $Greif (GEF.US)$ +4.6% (In reaction to earnings/guidance)
• $Olema Pharmaceuticals (OLMA.US)$ +4.3% (an...
21
When allocating stocks to your portfolio you want them to increase in value obviously so you can make profit. You want good companies that provide value in a bull and bear market within sectors and industries that are trending up. You want good companies that are heavily invested by hedge funds and ETF’s. And you dont want too much volatility in the price action. You may also want defensive stocks that may provide a cushion to a falling market. Sometimes you will rotate investmen...
5
5
No comment yet
70648215 : This is a real deal for long term
Dan’l OP 70648215 : It’s been a real deal for short-term trading, too, with crazy high gains on $Oklo Inc (OKLO.US)$ and $Centrus Energy (LEU.US)$ lately, buUut… every penny realized goes into growing my share counts as long-term investments.
Example: $NuScale Power (SMR.US)$ NuScale Power’s 20.4 M in revenue this year is expected to be over ten times higher next year, and I’m also buying $Fluor (FLR.US)$, which owns over half.
102875548 :
